The Department of Health and Human Services appears willing to take its contentious 340B Rebate Model Pilot Model back to the drawing board. After a lawsuit filed by hospitals secured a last-minute ...

Good afternoon, everyone. My name is Mary Liu, and I'm one of the associates on the healthcare investment banking team at JPMorgan. It's my pleasure to introduce our next presentation from Vir ...

Understanding how much you earn and spend is the key to getting control of your finances. Creating a budget gives you a better sense of where your money is going and can help you achieve financial ...

SAN FRANCISCO - Vir Biotechnology, Inc. (NASDAQ:VIR), currently trading at $5.72 and with a market capitalization of approximately $797 million, announced Monday that its combination therapy of ...